NU5455
Code | Size | Price |
---|
TAR-T64204-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T64204-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T64204-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
NU5455 is a selective, potent, orally active inhibitor of DNA-PKcs. NU5455 enhances the efficacy of locally released doxorubicin in liver tumour xenografts without causing any adverse effects. nU5455 enhances the efficacy and toxicity of topoisomerase inhibitors administered parenterally.
CAS:
1257235-99-6
Molecular Weight:
595.71
Purity:
0.98
SMILES:
CN(C(=O)CN1CCOCC1)c1ccc2sc3c(cccc3c2c1)-c1cccc2c1oc(cc2=O)N1CC2CCC(C1)O2